Nagpur, Maharashtra
GST No. 27AMPPS8870F1Z9
Call 08048989600
Send Enquiry
Minimum Order Quantity: 10 Strip
| Packaging Type | Strip |
| Brand | Musligra Gold Capsules |
| Pack Size | 1x10 |
| Composition | Herbal ED |
| Dosage | 1 capsule |
| Shelf life | 36 months |
| Country of Origin | Made in India |
Safed Musli
Ashwagandha
Shilajit
Kaunch Beej, Gokshura, etc. (varies by brand)
Boosts vitality and general stamina
May improve testosterone levels naturally
Traditionally used as a rejuvenator (Rasayana) in Ayurveda
Usually 1 capsule twice daily with milk or as directed by a physician
Generally safe if taken as per dose
Mild gastric discomfort in sensitive individuals
Marketed more as a general strength and energy booster, not as specialized as Musligra Gold.
π Musligra Capsule π§ͺ Composition:Safed Musli
Ashwagandha
Kaunch Beej
Shilajit
Gokshura
Promotes sexual stamina, libido, and male fertility
Used in cases of fatigue, erectile weakness, and low energy
Improves muscle strength and endurance
1β2 capsules per day after meals with milk or water
Rarely, acidity or minor headaches
Avoid overdose; consult doctor for long-term use
Positioned as a mid-range aphrodisiac supplement, effective for daily stamina.
π’ Musligra Gold Capsule (Most Potent) π§ͺ Composition:All of Musligra's ingredients, plus:
Swarna Bhasma (Gold ash)
Kesar (Saffron)
Rajat Bhasma (Silver ash)
More concentrated Shilajit extract
Enhances libido, sexual performance, and sperm quality
Acts as a full body rejuvenator
Supports mental alertness and mood
1 capsule per day, ideally at night with milk
Safe under proper dose
Not recommended in hypertension or cardiac conditions without medical advice
Premium product used more in performance enhancement and restorative therapy in traditional Ayurvedic practice.
Additional Information:
View Complete details
Minimum Order Quantity: 10 Vial
| Packaging Type | Vial |
| Brand | Reditux 600 mg |
| Manufacturer | Dr. Reddy's |
| Also gives | PCD Pharma Franchise |
| Country of Origin | Made in India |
| Strength | 600 mg |
π Manufacturer: Dr. Reddyβs Laboratories
π Composition: Rituximab 600 mg (also available in 100 mg & 500 mg vials)
π Indications:
Non-Hodgkinβs Lymphoma (NHL)
Chronic Lymphocytic Leukemia (CLL)
Rheumatoid Arthritis (with methotrexate)
Granulomatosis with polyangiitis & microscopic polyangiitis
βοΈ Mechanism: Targets CD20 on B cells β causes cell lysis via ADCC & CDC
π Administration: Intravenous infusion, under close medical supervision
β±οΈ Dose Schedule:
NHL: 375 mg/mΒ² IV weekly x 4β8 doses
RA: 1000 mg IV on days 1 & 15 (with MTX)
β οΈ Common Side Effects:
Infusion-related reactions (fever, chills, hypotension)
Infections (esp. respiratory)
Cytopenias, rare PML (progressive multifocal leukoencephalopathy)
π§ Storage: 2β8Β°C (do not freeze); protect from light
π Notable Points:
Indiaβs first biosimilar Rituximab (since 2007)
Most widely used brand among oncologists
Supported by vast post-marketing safety data
π Manufacturer: Intas Pharmaceuticals
π Composition: Rituximab 100 mg (also in 500 mg)
π Indications: Same as Reditux
βοΈ Mechanism: CD20-directed cytolytic antibody
π Administration: IV infusion; slow titration to avoid infusion reactions
β οΈ Common Side Effects:
Infusion reactions, fever
Hypotension, fatigue, infections
π§ Storage: 2β8Β°C, do not freeze
π Notable Points:
Intas is known for quality biosimilars
Gaining strong market share as an affordable alternative
Used in both cancer centers and rheumatology clinics
π Manufacturer: Alkem Laboratories
π Composition: Rituximab 100 mg (also available in 500 mg)
π Indications: NHL, CLL, RA, GPA/MPA
π Administration: IV infusion; pre-medication needed
β οΈ Side Effects: Same as above biosimilars
π§ Storage: 2β8Β°C, protect from freezing and light
π Notable Points:
Available in limited cancer treatment centers
Less widely prescribed compared to Reditux and Mabtas
Considered an economical option
π Manufacturer: Emcure Pharmaceuticals
π Composition: Rituximab 500 mg vial
π Indications: NHL, CLL, RA, GPA/MPA
π Administration: IV route; slow initial infusion required
β οΈ Side Effects:
Similar to other rituximab brands: infusion reactions, infections
π§ Storage: Refrigerated (2β8Β°C)
π Notable Points:
Emcureβs Rituximab biosimilar
Not as widely available or prescribed as Reditux or Mabtas
Growing acceptance in government tenders and cost-sensitive settings
Additional Information:
View Complete details
Minimum Order Quantity: 10 Vial
| Brand Name | Mycidac - C |
| Manufacturer | Cadila Pharma |
| Injection Routes | Subcutaneous (SC) |
| Country of Origin | Made in India |
Generic Name: Mycophenolate mofetil + Prednisolone
Dosage Form: Tablet / Capsule
Strength: Commonly Mycophenolate mofetil 500 mg + Prednisolone (variable dose)
π₯ Indications:Prevention of organ transplant rejection (kidney, heart, liver)
Autoimmune diseases needing immunosuppression (e.g., lupus nephritis, rheumatoid arthritis)
Mycidac C combines two immunosuppressants β Mycophenolate mofetil and Prednisolone β to suppress the immune system, helping prevent organ rejection and control autoimmune conditions.
Mycophenolate mofetil blocks purine synthesis, reducing lymphocyte proliferation.
Prednisolone is a corticosteroid that lowers inflammation and immune response.
Mycophenolate mofetil: Inhibits lymphocyte growth by blocking inosine monophosphate dehydrogenase.
Prednisolone: Decreases inflammatory mediator production via gene regulation.
Taken orally, usually twice daily.
Dose adjusted based on patient condition and transplant type.
Often combined with other immunosuppressants (e.g., cyclosporine).
Nausea, vomiting, diarrhea
Increased infection risk
Leukopenia (low white blood cells)
High blood pressure
High blood sugar
Weight gain and mood changes (from prednisolone)
Regular blood count monitoring.
Avoid live vaccines.
Use cautiously if active infections present.
Dose adjustments may be necessary for kidney or liver issues.
Various pharmaceutical companies specializing in transplant and immunosuppressive drugs.
Additional Information:
View Complete details
Minimum Order Quantity: 10 Box
| Strength | 100 mg |
| Storage Condition | 15 DegreeC and 30 DegreeC |
| Form | Tablet |
Generic Name: Lorlatinib
Brand Name: Lorbiqua
Manufacturer: Pfizer
Drug Class: ALK (Anaplastic Lymphoma Kinase) Tyrosine Kinase Inhibitor
Form: Film-coated tablets
Route: Oral
Indications: Treatment of ALK-positive non-small cell lung cancer (NSCLC)
Lorbiqua 25 mg tablets are typically used to fine-tune the dosage or provide lower starting doses for patients who may not tolerate the 100 mg dose due to side effects or drug interactions. It is also used for dose adjustments during treatment.
π Key Points:Used alone or in combination to create custom doses (e.g., 75 mg/day using 3 x 25 mg tablets).
Suitable for patients with dose-limiting toxicities on 100 mg.
Pink, round, film-coated tablet with βPfizerβ on one side and β25β on the other.
Lorbiqua 100 mg is the standard once-daily dose for adult patients with ALK-positive metastatic NSCLC, especially after progression on prior ALK inhibitors like crizotinib, ceritinib, or alectinib.
π Key Points:First choice in later-line treatment of ALK-positive NSCLC.
Demonstrates brain penetration, making it effective in treating CNS metastases.
Pink, oval-shaped, film-coated tablet with βPfizerβ on one side and β100β on the other.
Lorlatinib selectively inhibits ALK and ROS1 tyrosine kinases. These are genetic mutations responsible for driving tumor growth in certain NSCLC subtypes. Lorlatinib blocks the signaling that allows cancer cells to grow and survive.
It is especially potent against resistant ALK mutations and brain metastases due to high CNS penetration.
π Clinical Use:For adults with ALK-positive metastatic NSCLC whose disease has progressed on:
Crizotinib and at least one other ALK inhibitor, OR
Alectinib or ceritinib as first-line treatment
Hypercholesterolemia and hypertriglyceridemia
Peripheral edema
Weight gain
CNS effects: mood changes, cognitive impairment
Fatigue
Diarrhea
Joint pain
π§ CNS effects are more frequent with lorlatinib compared to other ALK inhibitors.
π§ͺ Monitoring:Lipid profile regularly (every 2 weeks initially)
Liver function tests
CNS symptoms (confusion, speech changes, mood swings)
Store below 30Β°C (86Β°F)
Keep in original package to protect from moisture
Generally 24 months from manufacturing when stored properly
Effective after resistance to first- and second-generation ALK inhibitors
Penetrates blood-brain barrier, helpful in CNS metastasis
Active against multiple ALK resistance mutations
Additional Information:
View Complete details